Literature DB >> 21654842

Molecular basis of hereditary C1q deficiency--revisited: identification of several novel disease-causing mutations.

L Schejbel1, L Skattum, S Hagelberg, A Åhlin, B Schiller, S Berg, F Genel, L Truedsson, P Garred.   

Abstract

C1q is the central pattern-recognition molecule in the classical pathway of the complement system and is known to have a key role in the crossroads between adaptive and innate immunity. Hereditary C1q deficiency is a rare genetic condition strongly associated with systemic lupus erythematosus and increased susceptibility to bacterial infections. However, the clinical symptoms may vary. For long, the molecular basis of C1q deficiency was ascribed to only six different mutations. In the present report, we describe five new patients with C1q deficiency, present the 12 causative mutations described till now and review the clinical spectrum of symptoms found in patients with C1q deficiency. With the results presented here, confirmed C1q deficiency is reported in 64 patients from at least 38 families.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21654842     DOI: 10.1038/gene.2011.39

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  32 in total

1.  Rothmund-Thomson syndrome and glomerulonephritis in a homozygous C1q-deficient patient due to a Gly164Ser C1qC mutation.

Authors:  Alberto López-Lera; Juan M Torres-Canizales; Sofía Garrido; Adelaida Morales; Margarita López-Trascasa
Journal:  J Invest Dermatol       Date:  2013-10-24       Impact factor: 8.551

Review 2.  Complement System: a Neglected Pathway in Immunotherapy.

Authors:  Anne Bordron; Cristina Bagacean; Adrian Tempescul; Christian Berthou; Eléonore Bettacchioli; Sophie Hillion; Yves Renaudineau
Journal:  Clin Rev Allergy Immunol       Date:  2020-04       Impact factor: 8.667

3.  Identification of novel coding mutation in C1qA gene in an African-American pedigree with lupus and C1q deficiency.

Authors:  B Namjou; M Keddache; D Fletcher; S Dillon; L Kottyan; G Wiley; P M Gaffney; B E Wakeland; C Liang; E K Wakeland; R H Scofield; K Kaufman; J B Harley
Journal:  Lupus       Date:  2012-04-03       Impact factor: 2.911

Review 4.  Evasion and interactions of the humoral innate immune response in pathogen invasion, autoimmune disease, and cancer.

Authors:  Trisha A Rettig; Julie N Harbin; Adelaide Harrington; Leonie Dohmen; Sherry D Fleming
Journal:  Clin Immunol       Date:  2015-07-02       Impact factor: 3.969

Review 5.  Biomarkers for kidney involvement in pediatric lupus.

Authors:  Beatrice Goilav; Chaim Putterman; Tamar B Rubinstein
Journal:  Biomark Med       Date:  2015       Impact factor: 2.851

6.  C1q rs292001 polymorphism and C1q antibodies in juvenile lupus and their relation to lupus nephritis.

Authors:  Y M Mosaad; A Hammad; Z Fawzy; A El-Refaaey; Z Tawhid; E M Hammad; L F Youssef; E A A ElAttar; D F Radwan; I M Fawzy
Journal:  Clin Exp Immunol       Date:  2015-07-28       Impact factor: 4.330

Review 7.  Monogenic autoimmunity.

Authors:  Mickie H Cheng; Mark S Anderson
Journal:  Annu Rev Immunol       Date:  2012-01-06       Impact factor: 28.527

Review 8.  Monogenic systemic lupus erythematosus: insights in pathophysiology.

Authors:  Ezgi Deniz Batu
Journal:  Rheumatol Int       Date:  2018-05-15       Impact factor: 2.631

9.  Early Complement Component Deficiency in a Single-Centre Cohort of Pediatric Onset Lupus.

Authors:  Sagar Bhattad; Amit Rawat; Anju Gupta; Deepti Suri; Ravinder Garg; Martin de Boer; Taco W Kuijpers; Surjit Singh
Journal:  J Clin Immunol       Date:  2015-11-13       Impact factor: 8.317

Review 10.  Rare variants, autoimmune disease, and arthritis.

Authors:  Sharon A Chung; Anthony K Shum
Journal:  Curr Opin Rheumatol       Date:  2016-07       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.